Novavax announced that the company has been awarded a contract by the U.S. Department of Defense (DoD) for the manufacturing of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate.
Novavax Wins Department of Defense Contract for COVID-19 Vaccine
novavax
Stock Market Booms with COVID-19 Vaccine News
For key manufacturers, numbers are beginning to reflect the potential financial impact of vaccine development. Hopeful investors have surged the price of Moderna, whose press releases are dominating the news on vaccine development in the US. Recently....